Skip to content

4548.T

SEIKAGAKU CORPORATION

プライム · 医薬品 · 医薬品 · JP

JPY 705.00
−0.14%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue36.6B36.6B39.4B36.2B33.5B
Cost of Revenue5.0B20.7B20.2B19.3B15.4B
Gross Profit3.7B16.0B19.2B16.9B18.0B
Operating Expenses
R&D Expense
SG&A Expense4.1B16.6B17.8B16.4B15.9B
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses4.1B16.6B17.8B16.4B15.9B
Cost and Expenses37.3B37.3B38.0B35.8B31.3B
Operating Income (EBIT)(660.0M)(660.0M)1.3B433.0M2.1B
Non-Operating
Interest Income25.0M110.0M162.0M150.0M51.0M
Interest Expense1.0M9.0M4.0M4.0M5.0M
Net Interest Income24.0M101.0M158.0M146.0M46.0M
Other Non-Op Income/Expense232.0M2.3B600.0M1.3B955.0M
Non-Operating Income (excl Interest)248.0M2.3B729.0M1.2B916.0M
EBT (Pre-Tax Income)(132.0M)1.5B1.9B1.7B3.1B
Income Tax Expense67.0M36.0M718.0M(495.0M)832.0M
Bottom Line
Net Income1.5B1.5B1.2B2.2B2.2B
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income1.5B1.5B1.2B2.2B2.2B
Per Share
Basic EPS¥27¥27¥22¥40¥40
Diluted EPS¥27¥27
Revenue Per Share¥671¥671¥721¥664¥606
Shares
Basic Shares Outstanding54.6M54.6M54.6M54.6M55.2M
Diluted Shares Outstanding
Profitability Metrics
EBITDA1.3B3.1B1.9B3.3B
D&A2.0B1.8B1.5B1.2B
EBIT(660.0M)(660.0M)1.3B433.0M2.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026